Neopterin formation through radical scavenging of superoxide by the macrophage synthesised antioxidant 7,8-dihydroneopterin.

7,8-Dihydroneopterin Antioxidant Atherosclerotic plaque Macrophages Neopterin Radiolysis Superoxide

Journal

Free radical biology & medicine
ISSN: 1873-4596
Titre abrégé: Free Radic Biol Med
Pays: United States
ID NLM: 8709159

Informations de publication

Date de publication:
20 05 2020
Historique:
received: 05 12 2019
revised: 26 02 2020
accepted: 02 03 2020
pubmed: 8 3 2020
medline: 22 6 2021
entrez: 8 3 2020
Statut: ppublish

Résumé

Clinical measurement of neopterin has been extensively used as a marker of inflammation but the in vivo mechanism generating neopterin is poorly understood. Neopterin is described as the oxidation product of 7,8-dihydroneopterin, a potent antioxidant generated by monocyte/macrophages in response to interferon-γ. While peroxyl and hydroxyl scavenging generates dihydroxanthopterin, hypochlorite efficiently oxidises 7,8-dihydroneopterin into neopterin, but this reaction alone does not explain the high levels of neopterin seen in clinical data. Here, we examine whether superoxide scavenging by 7,8-dihydroneopterin generates neopterin. U937 cells incubated with oxLDL showed a time dependent increase superoxide and 7,8-dihydroneopterin oxidation to neopterin. Neopterin generation in oxLDL or phorbol ester treated U937 cells or human monocytes was inhibited by apocynin and PEG-SOD. Addition of the myeloperoxidase inhibitor 4-aminobenzoic acid hydrazide (ABAH) had no effect of the superoxide generation or neopterin formation. 7,8-Dihydroneopterin reacted with superoxide/hydroxy radical mixtures generated by X-ray radiolysis to give neopterin. Formation of neopterin by superoxide derived from the xanthine/xanthine oxidase system was inhibited by superoxide dismutase. Neopterin formation was inhibited by apocynin in phorbol ester treated human carotid plaque rings in tissue culture. These results indicate that 7,8-dihydroneopterin scavenges superoxide and is subsequently oxidised into neopterin in cellular and cell-free experimental systems.

Identifiants

pubmed: 32145301
pii: S0891-5849(19)32459-1
doi: 10.1016/j.freeradbiomed.2020.03.002
pii:
doi:

Substances chimiques

Antioxidants 0
Superoxides 11062-77-4
7,8-dihydroneopterin 1218-98-0
Neopterin 670-65-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

142-151

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflicts of interest in this work.

Auteurs

Gregory Baxter-Parker (G)

Free Radical Biochemistry, School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.

Hannah M Prebble (HM)

Free Radical Biochemistry, School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.

Sean Cross (S)

Free Radical Biochemistry, School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.

Nina Steyn (N)

Free Radical Biochemistry, School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.

Anastasia Shchepetkina (A)

Free Radical Biochemistry, School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.

Barry D Hock (BD)

Haematology Research, Department of Pathology and Biomedical Sciences, University of Otago Christchurch, New Zealand.

Andrew Cousins (A)

Department of Medical Physics and Bioengineering, Christchurch Hospital, Canterbury District Health Board, New Zealand.

Steven P Gieseg (SP)

Free Radical Biochemistry, School of Biological Sciences, University of Canterbury, Christchurch, New Zealand; Department of Radiology, University of Otago Christchurch, New Zealand; European Organization for Nuclear Research (CERN), Geneva, Switzerland. Electronic address: Steven.Gieseg@canterbury.ac.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH